title: Fatality in a patient treated with dabigatran.
authors.affiliation: Department of Medicine, Kaplan Medical Centre, Rehovot, Hebrew University Hadassah Medical School, Jerusalem 91120, Israel. amiMD@clalit.org.il
authors.forename: Ami
authors.initials: A
authors.lastname: Schattner
authors.forename: Natasha
authors.initials: N
authors.lastname: Kozak
authors.forename: Joshua
authors.initials: J
authors.lastname: Friedman
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D012771:Shock, Hemorrhagic / Q000139:chemically induced*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran